This pilot study will be performed to investigate whether the cantharidin-induced blister method is a useful alternative for the vacuum blister method in patients with acute or chronic CRPS.Replacement of the vacuum blister method by the filter disc…
ID
Source
Brief title
Condition
- Autoimmune disorders
- Fractures
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Bioactive substances: cytokines, nitric oxide and other vasoactive mediators.
Secondary outcome
none
Background summary
In research with Complex Regional Pain Syndrome (CRPS) patients, bioactive
substances are being measured in blister fluid from the involved hand or foot
in comparison with the non-involved hand or foot. This reflects disease
activity and displays effectiveness of pharmaceutical intervention during the
course of the disease.
In order to replace the so far standard vacuum blister method by a more
convenient method, the usefulness should be tested simultaneously, both in
healthy controls and CRPS patients in the acute (inflammatory) phase and the
chronic (trophic) phase of the disease. It is not known whether locally formed
mediators are reflected similar by these two methods.
Study objective
This pilot study will be performed to investigate whether the
cantharidin-induced blister method is a useful alternative for the vacuum
blister method in patients with acute or chronic CRPS.
Replacement of the vacuum blister method by the filter disc method could be
more appropriate for the patient and result in better blisters with higher
quantities.
Study design
In a parallel study blister fluid obtained after induction of cantharidin or
vacuum suction, measurements to compare the concentrations of bioactive
substances will be performed.
Study burden and risks
A disadvantage could be the application of another blister which has been
generated by the cantharidin containing filter disc. The healing of this
blister should be faster as the vacuum suction blister, which in some cases
reveal scars.
The simultaneous induction of these two types of blisters is not time consuming
nor expected to induce risk factors.
Postbus 2040
3000 CA Rotterdam
Nederland
Postbus 2040
3000 CA Rotterdam
Nederland
Listed location countries
Age
Inclusion criteria
acute or chronic CRPS
Exclusion criteria
use of immunosuppressives
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL11557.078.06 |